Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.47	25.29	30.61	31.83	218.31
Short-Term Investments	121.14	207.64	171.12	259.41	-
Cash & Short-Term Investments	133.61	232.94	201.73	291.23	218.31
Cash Growth	-42.64%	15.47%	-30.73%	33.40%	1056.36%
Prepaid Expenses	2.28	2.65	2.65	3.88	2.5
Total Current Assets	135.9	235.59	204.38	295.12	220.81
Property, Plant & Equipment	35.47	37.74	6.7	5.64	2.48
Other Long-Term Assets	4.15	4.34	9.42	4.35	0.3
Total Assets	175.52	277.67	220.5	305.1	223.59
Accounts Payable	7.73	4.58	6.78	7.84	3.92
Accrued Expenses	14.44	14.82	12.57	9.53	7.04
Current Portion of Leases	2.7	1.48	1.83	1.74	-
Other Current Liabilities	0.77	0.95	0.52	0.09	0.42
Total Current Liabilities	25.64	21.83	21.7	19.2	11.38
Long-Term Leases	15.33	15.41	-	-	-
Other Long-Term Liabilities	3.09	3.34	3.36	-	0.03
Total Liabilities	44.06	40.58	25.06	19.2	11.41
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	714.98	693.25	531.68	505.72	319.61
Retained Earnings	-583.56	-456.39	-334.56	-219.12	-107.43
Comprehensive Income & Other	0.04	0.22	-1.69	-0.71	-
Total Common Equity	131.46	237.09	195.44	285.9	212.18
Shareholders' Equity	131.46	237.09	195.44	285.9	212.18
Total Liabilities & Equity	175.52	277.67	220.5	305.1	223.59
Total Debt	18.03	16.89	1.83	1.74	-
Net Cash (Debt)	115.59	216.05	199.9	289.49	218.31
Net Cash Growth	-46.50%	8.08%	-30.95%	32.61%	1072.38%
Net Cash Per Share	1.52	3.58	4.22	6.29	17.49
Filing Date Shares Outstanding	55.15	54.89	47.71	47.02	45.37
Total Common Shares Outstanding	55.15	54.89	47.7	46.99	42.49
Working Capital	110.25	213.76	182.68	275.91	209.43
Book Value Per Share	2.38	4.32	4.10	6.08	4.99
Tangible Book Value	131.46	237.09	195.44	285.9	212.18
Tangible Book Value Per Share	2.38	4.32	4.10	6.08	4.99
Machinery	10.33	8.97	5.72	4.38	2.72
Construction In Progress	-	0.34	1.64	0.67	-
Leasehold Improvements	1.7	1.58	0.88	0.88	0.45

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q